Loading...
Both low-dose aspirin (LDA) and clopidogrel reduce platelet function and increase the risk for upper gastrointestinal bleeding. To evaluate whether the combination of these two drugs magnifies that risk, whether acid reduction from a proton-pump inhibitor (PPI) might mitigate any increased risk, and whether outcomes vary by Helicobacter pylori infection or CYP2C19 genotype status, investigators conducted a four-arm crossover study involving 20 healthy volunteers in Japan.
The study cohort was selected for variation in H. pylori infection status and CYP2C19 genotype status (rapid metabolizers, intermediate metabolizers, and poor metabolizers). Participants received each of four 7-day regimens in randomized order: aspirin (100 mg/day), clopido…